Veracyte (VCYT) Misses Q2 EPS by 7c

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/16/2026

1. CRWV
2. NVDA
3. SPY
4. BAC
5. BLK
6. CAT
7. AA
8. RKLB
9. RXRX
10. NOW

Go back to Veracyte (VCYT) Misses Q2 EPS by 7c

Veracyte Announces Second Quarter 2016 Financial Results

August 3, 2016 4:05 PM EDT

SOUTH SAN FRANCISCO, Calif., Aug. 3, 2016 /PRNewswire/ -- Veracyte, Inc. (NASDAQ: VCYT) today announced financial results for the second quarter ended June 30, 2016 and provided an update on recent business progress. For the second quarter of 2016, revenue was $14.7 million, an increase of 23%, compared to $11.9 million for the second quarter of 2015. Afirma Gene Expression Classifier (GEC) volume grew to 5,832 tests, an increase of 23%, compared to the same period in 2015. These results bring first-half 2016 revenue to $28.2 million and Afirma GEC volume to... More